ADVENTRX Pharmaceuticals Inc. (ANX) Completes Name Change to "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
3/11/2013 10:11:06 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Corporate Name Change to "Mast Therapeutics, Inc."; Ticker Symbol Change to "MSTX"
3/1/2013 9:51:07 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) to Develop ANX-188 for Complications of Arterial Disease
3/1/2013 9:42:12 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Reviews Data Supporting Development of ANX-188 in New Indications
2/26/2013 9:44:50 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) to Present at the Cowen and Company 33rd Annual Health Care Conference on March 4
2/25/2013 6:34:14 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Initiates Thorough QT/QTc Clinical Study Of ANX-188
2/11/2013 9:17:24 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 12
2/5/2013 6:57:46 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Initiates Pivotal Phase 3 Study of ANX-188
1/30/2013 9:31:05 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) Announces Appointment of Chief Financial Officer
1/4/2013 7:06:38 AM
More...
|
ADVENTRX Pharmaceuticals Inc. (ANX) to Present at the 6th Annual OneMedForum Emerging Company Finance Conference on January 8
1/2/2013 6:50:17 AM
More...
|
|